Core Insights - Henry Schein, Inc. reported strong fourth quarter sales growth, achieving the highest sales growth in 15 quarters, driven by global equipment, specialty products, and technology businesses [10][11] - The company is on track to exceed its goal of having over 50% of non-GAAP operating income from high-growth, high-margin businesses by the end of its strategic planning cycle in 2027 [11] - The implementation of the BOLD+1 strategic plan is progressing well, with significant advancements in e-commerce and innovative solutions for customer care [12][13] Financial Performance - Global sales for the fourth quarter reached $3.4 billion, reflecting a 7.7% growth compared to 2024, with constant currency sales growth of 5.8% [32] - Non-GAAP net income for the fourth quarter was $160 million, or $1.34 per diluted share, compared to $149 million, or $1.19 per diluted share in the prior year [34] - The effective tax rate for 2025 on a non-GAAP basis was 22.7%, slightly higher than the previous year's rate of 22% [33] Business Segments - The Global Distribution and Value Added Services Group saw sales growth of 7%, with U.S. dental merchandise sales growing by 3.6% and U.S. dental equipment sales increasing by 10.6% [35] - The Global Specialty Products Group experienced a sales increase of 14.6%, driven by strong performance in implants and biomaterials [38] - The Global Technologies Group reported total sales growth of 8.4%, with significant contributions from practice management software [38] Strategic Initiatives - The company is focusing on value creation initiatives expected to deliver over $200 million in operating income improvement over the next few years [39] - A new partnership with Amazon Web Services aims to integrate generative AI technology into Henry Schein's products, enhancing customer service and operational efficiency [29][30] - The rollout of the global e-commerce platform, henryschein.com, is expected to be completed for U.S. dental and Canadian customers in the first quarter of the year [12] Market Outlook - The U.S. dental market is showing signs of stability and positive growth, with patient traffic remaining stable and a favorable outlook for equipment investments [16][55] - International dental merchandise sales grew by 9.2%, benefiting from a weaker U.S. dollar and strong performance across various markets [23] - The company anticipates 2026 sales growth of 3% to 5% over 2025, with non-GAAP diluted EPS expected to be in the range of $5.23 to $5.37 [41]

Core Insights - Ace investor Mukul Mahavir Agrawal reshuffled his Rs 6,500-crore equity portfolio during the December quarter, reflecting a mix of fresh bets and tactical adjustments following sharp stock-specific corrections and a selloff in smallcap stocks in 2025 [18] Company Summaries - **Hindustan Construction**: Agrawal acquired a 1.68% stake, amounting to 4.40 crore shares, after the stock experienced a correction of over 30% in the past year [1] - **Alcargo Logistics**: Agrawal purchased a 2.9% stake in the company, which has seen a decline of about 80% over the last year. Alcargo specializes in integrated logistics services [2] - **Sudeep Pharma**: A 1.3% stake was acquired by Agrawal, with the stock down nearly 30% in the last year. Sudeep is a manufacturer of mineral-based pharmaceutical excipients and specialty ingredients [3] - **Vasa Denticity**: Agrawal increased his stake by 0.4%, bringing his total holding to 2.4%. The company is a leading B2B e-commerce platform for dental products [4] - **Vikran Engineering**: Agrawal increased his stake by 0.2%. The stock is down 10% from its issue price of Rs 97 since its market debut in September last year [7] - **N R Agrawal**: A marginal stake increase of 0.1% was made, with the stock down nearly 20% from its 52-week high of Rs 514 [8] - **Monolithisch**: Agrawal reduced his stake by 0.2% to 2.76%, with the stock down 20.5% from its 52-week high of Rs 607 [9] - **Pearl Global**: The investor offloaded 0.2% in the company, which has fallen nearly 15% in January alone [10] - **InfoBeans Technologies**: Agrawal reduced his stake by 0.2% to 3.9%, with the stock up 97% in the last year [11] - **Autoriders**: A stake reduction of 0.7% occurred, with the stock rising over 1,100% in the last year [12] - **Zota Healthcare**: Agrawal reduced his stake by 0.8%, with the stock up nearly 40% in the last year [13] - **ASM Technologies**: A stake reduction of 0.4% was noted, with the stock having doubled in the last year, rising about 115% [14] - **Stanley Lifestyles**: Agrawal appears to have exited the stock, which is down nearly 50% in the last year [15]